A Novel in Vivo Rabbit Model of Hypercatabolic Critical Illness Reveals a Biphasic Neuroendocrine Stress Response
The DOI matches its OpenAlex record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
High doses of GH, used to induce anabolism in prolonged critically ill patients, unexpectedly increased mortality. To further explore underlying mechanisms, a valid animal model is needed. Such a model is presented in this study. Seven days after arterial and venous cannulae placement, male New Zealand White rabbits were randomly allocated to a control or a critically ill group. To induce prolonged critical illness, a template controlled 15% deep dermal burn injury was imposed under combined general and regional (paravertebral) anesthesia. Subsequently, critically ill rabbits received supplemental analgesia and were parenterally fed with glucose, insulin, amino acids, and lipids. On d 1 and d 8 after randomization, acute and chronic spontaneous hormonal profiles of GH, TSH, and PRL secretion were obtained by sampling blood every 15 min for 7 h. Furthermore, GH, TSH, and PRL responses to an iv bolus of GH-releasing peptide 2 (GHRP-2) + TRH were documented on d 0, 1, and 8. Hemodynamic status and biochemical parameters were evaluated on d 0, 1, 3, 5, and 8, after which animals were killed and relative wet weight and water content of organs was determined. Compared with controls, critically ill animals exhibited transient metabolic acidosis on d 1 and weight loss, organ wasting, systolic hypertension, and pronounced anemia on d 8. On d 1, pulsatile GH secretion doubled in the critically ill animals compared with controls, and decreased again on d 8 in the presence of low plasma IGF-I concentrations from d 1 to d 8. GH responses to GHRP-2 + TRH were elevated on d 1 and increased further on d 8 in the critically ill animals. Mean TSH concentrations were identical in both groups on d 1 and 8, in the face of dramatically suppressed plasma T(4) and T(3) concentrations in the critically ill animals. PRL secretion was impaired in the critically ill animals exclusively on d 8. TSH and PRL responses to GHRP-2 and TRH were increased only on d 1. In conclusion, this rabbit model of acute and prolonged critical illness reveals several of the clinical, biochemical, and endocrine manifestations of the human counterpart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Approximate entropy as a measure of system complexity.
Pincus, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2297 · Cited by 5,811
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
Dangerous dogmas in medicine: the nonthyroidal illness syndrome
De Groot, L. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5364 · Cited by 505
Fliers, E., Guldenaar, S. E. F., Wiersinga, W. M., & Swaab, D. F. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4404 · Cited by 206
Veldhuis, J. D., Straume, M., Iranmanesh, A., Mulligan, T., Jaffe, C., Barkan, A., Johnson, M. L., & Pincus, S. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.3.r721 · Cited by 127
Self-citationKakucska, I., Romero, L. I., Clark, B. D., Rondeel, J. M. M., Qi, Y., Alex, S., Emerson, C. H., & Lechan, R. M. (2008) · Neuroendocrinology · doi:10.1159/000126649 · Cited by 74
van Haasteren, G. A., van der Meer, M. J., Hermus, A. R., Linkels, E., Klootwijk, W., Kaptein, E., van Toor, H., Sweep, C. G., Visser, T. J., & de Greef, W. J. (1994) · Endocrinology · doi:10.1210/endo.135.4.7925094 · Cited by 69
Research works printed but not linked: 37
- Streat, 1987, Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients., J Trauma, 27, 262, 10.1097/00005373-198703000-00006 · DOI · Paper page
- Van den Berghe, 1997, The somatotropic axis in critical illness: effect of continuous growth hormone releasing hormone and GH releasing peptide-2 infusion., J Clin Endocrinol Metab, 82, 590
- Van den Berghe, 1998, Acute and prolonged critical illness as different neuroendocrine paradigms., J Clin Endocrinol Metab, 83, 1827
- Rivier, 1985, Involvement of corticotropin-releasing factor in ether stress inhibition of growth hormone secretion in the rat., Endocrinology, 117, 2478, 10.1210/endo-117-6-2478 · DOI · Paper page
- Ramsden, 1979, Effects of surgical stress and corticotrophin on the peripheral metabolism of thyroid hormones in rabbits., J Endocr, 82, 403, 10.1677/joe.0.0820403 · doi:10.1677/joe.0.0820403
- McIntyre H and Odell, 1974, Physiological control of growth hormone in the rabbit., Neuroendocrinology, 16, 8, 10.1159/000122548 · DOI
- Hu, 1998, A rabbit model for metabolic studies after burn injury., J Surg Res, 75, 153, 10.1006/jsre.1998.5274 · DOI
- Van den Berghe, 2000, A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness., J Clin Endocrinol Metab, 85, 183
- Van den Berghe, 1999, Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness., J Clin Endocrinol Metab, 84, 1311
- Verhaeghe, 1992, The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats., J Endocrinol, 134, 485, 10.1677/joe.0.1340485 · DOI
- Veldhuis, 1987, The pituitary gland secretes in bursts: appraising the nature of glandular secretary impulses by simultanuous multiple parameter deconvolution of plasma hormone concentrations., Proc Natl Acad Sci USA, 84, 7686, 10.1073/pnas.84.21.7686 · DOI · Paper page
- Imbimbo, 1994, Growth hormone releasing activity of hexarelin in humans: a dose response study., Eur J Clin Pharm, 46, 421, 10.1007/BF00191904 · DOI
- Van den Berghe, 1996, Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotropin-releasing hormone in critical illness., Clin Endocrinol, 45, 341, 10.1046/j.1365-2265.1996.00805.x · DOI · Paper page
- Elias, 1995, In vitro characterization of four novel classes of growth hormone-releasing peptide., Endocrinology, 136, 5694, 10.1210/endo.136.12.7588325 · doi:10.1210/endo.136.12.7588325 · Paper page
- Carmignac, 1998, Effects of growth hormone secretagogues on prolactin release in anesthetized dwarf (dw/dw) rats., Endocrinology, 139, 3590, 10.1210/endo.139.8.6148 · DOI
- Michelsen, 1982, Effect of an anabolic steroid on nitrogen balance and amino acid patterns after total hip replacement., J Trauma, 22, 410, 10.1097/00005373-198205000-00011 · doi:10.1097/00005373-198205000-00011
- Wallner, 1986, The anemia of thermal injury: mechanism of inhibition of erythropoiesis., Proc Soc Exp Biol Med, 181, 144, 10.3181/00379727-181-42236 · doi:10.3181/00379727-181-42236
- Carlson, 1987, Fluid retention and burn survival., J Trauma, 27, 127, 10.1097/00005373-198702000-00005 · doi:10.1097/00005373-198702000-00005
- Lawrence C and Atac, 1992, Hematologic changes in massive burn injury., Crit Care Med, 20, 1284, 10.1097/00003246-199209000-00015 · doi:10.1097/00003246-199209000-00015
- Wojnar, 1995, Alterations in the insulin like growth factor system in trauma patients, Am J Physiol, 268, R970
- Ross, 1991, Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I., Clin Endocrinol Oxf, 35, 47, 10.1111/j.1365-2265.1991.tb03495.x · DOI · Paper page
- Hartman, 1991, Temporal structure of in vivo growth hormone secretory events in humans, Am J Physiol, 260, E101
- Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach., Nature, 402, 656, 10.1038/45230 · DOI · Paper page
- Jaffe, 1993, Effects of a prolonged growth hormone-releasing peptide infusion on pulsatile GH secretion in normal men., J Clin Endocrinol Metab, 77, 1641
- Bowers, 2001, Unnatural growth hormone-releasing peptide begets natural ghrelin., J Clin Endocrinol Metab, 86, 1464, 10.1210/jcem.86.4.7431 · doi:10.1210/jcem.86.4.7431 · Paper page
- Pandya, 1998, Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation., J Clin Endocrinol Metab, 83, 1186
- Maheshwari, 1999, Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency., J Clin Endocrinol Metab, 84, 956
- Veldhuis, 2001, Lowering total plasma IGF-I concentrations by way of a novel, potent and selective GH-receptor antagonist, pegvisomant (B2036-PEG), augments the amplitude of GH secretory bursts and elevates basal nonpulsatile GH release in healthy women and men., J Clin Endocrinol Metab, 86, 3304
- Van den Berghe, 1998, Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin releasing hormone and its combination with growth hormone secretagogues., J Clin Endocrinol Metab, 83, 309
- Challa, 1993, Metabolic acidosis inhibits growth hormone secretion in the rat, Mechanisms of growth retardation. Am J Physiol, 265, E547
- Corsi, 1997, Effects of acute and chronic inflammation on plasma growth hormone levels in rats., Drugs Exp Clin Res, 23, 117
- Utiger, 1980, Decreased extrathyroidal triiodothyronine production in non thyroidal illness: benefit or harm?, Am J Med, 132, 144
- Phillips, 1984, Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome., J Trauma, 24, 116, 10.1097/00005373-198402000-00004 · DOI · Paper page
- Leon Sanz, 1997, Pituitary-thyroid function in patients with septic shock and its relation with outcome., Eur J Med Res, 28, 477
- Tache, 1976, Shift in adenohypophyseal activity during chronic intermittent immobilization of rats., Neuroendocrinology, 22, 325, 10.1159/000122641 · DOI · Paper page
- Viquerat, 1985, Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities., Am J Med, 78, 455, 10.1016/0002-9343(85)90338-9 · DOI
- Van den Berghe, 1999, Growth hormone releasing peptide-2 infusion synchronizes growth hormone, thyrotropin and prolactin release in prolonged critical illness., Eur J Endocrinol, 140, 17, 10.1530/eje.0.1400017 · DOI · Paper page
Cited by
How does blood glucose control with insulin save lives in intensive care?
Van den Berghe, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423506 · Cited by 550
Intensive insulin therapy protects the endothelium of critically ill patients
Langouche, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25385 · Cited by 467
Vanhorebeek, I., De Vos, R., Mesotten, D., Wouters, P. J., De Wolf-Peeters, C., & Van den Berghe, G. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17665-4 · Cited by 452
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., & Larsson, L. (2015) · Physiological Reviews · doi:10.1152/physrev.00028.2014 · Cited by 396
Beyond Low Plasma T3: Local Thyroid Hormone Metabolism during Inflammation and Infection
Boelen, A., Kwakkel, J., & Fliers, E. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0007 · Cited by 287
Metadata
- Authors
- Weekers, F., Herck, E. V., Coopmans, W., Michalaki, M. A., Bowers, C. Y., Veldhuis, J. D., & den Berghe, G. V.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2002-03-01
- Volume
- 143
- Issue
- 3
- Pages
- 764-774
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2033155942
- Cited by
- 78
- References
- 7
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.